February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car
February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.
February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical ...
February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to ...
February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Siemens Healthcare will highlight the Magnetom Essenza which features 30 mT/m gradients, reportedly delivering excellent ...
February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart Journal (2008; Vol. 155, Issue 1: 128-132).
February 18, 2008 - Treating patients who have occlusive femoropopliteal disease with paclitaxel-coated balloons during ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies, Niaspan (Abbott’s proprietary niacin extended-release) and simvastatin, offering patients a new option for reaching healthy lipid levels.
February 15, 2008 - Siemens received FDA 510(k) clearance for Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.
February 15, 2008 - The Sorin Group is launching the Sorin MEMO 3D Annuloplasty Ring for mitral valve repair clinical ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Siemens offers the Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.
February 14, 2008 - At age 20, Vanessa Cirillo suffered a heart attack caused by a virus. She recovered and lived a ...
February 2008 - Ken Willis, RT (R)(CV), is the radiology informatics PACS engineer for Baptist Health in Montgomery, AL. His healthcare system recently completed its first installation of LCDs in 27 operating rooms spread over three hospitals. The installation included 60 NDS Surgical Imaging DS 42-inch LCDs.
February 18, 2008
